CellSource Co., Ltd. (TYO:4880)
Japan · Delayed Price · Currency is JPY 308.00
-5.00 (-1.60%)
Oct 26, 2026, 3:30 PM JST
CellSource Market Cap
CellSource has a market cap or net worth of 6.11 billion as of October 26, 2026. It is the 31,989th most valuable company in the world and the 2,926th biggest in Japan. Its market cap has decreased by 40.68% in one year.
Market Cap
6.11B
Enterprise Value
1.33B
Revenue
3.67B
Global Rank
Country Rank
#2,926 Japan
PE Ratio
87.23
ChartMarket Cap Chart
Since October 29, 2019, CellSource's market cap has decreased from 13.48B to 6.11B, a decrease of -54.64%. That is a compound annual growth rate of -10.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 6.11B | -22.70% |
| Dec 30, 2025 | 7.91B | -52.01% |
| Dec 30, 2024 | 16.48B | -34.91% |
| Dec 29, 2023 | 25.32B | -66.16% |
| Dec 30, 2022 | 74.83B | -26.01% |
| Dec 30, 2021 | 101.14B | 51.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 29, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OncoTherapy Science | 7.35B |
| Nano Holdings | 7.17B |
| StemCell Institute | 7.16B |
| Chiome Bioscience | 7.10B |
| ADR Biomedical Holdings | 6.68B |
| MEDINET | 6.24B |
| TMS Co., Ltd. | 6.03B |
| SUSMED,Inc. | 5.83B |